Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Coronavirus – UK launches clinical trial of BCG vaccine

Pelistocene Megafauna Extinction

CCRAS-NARIP Govt Research Recruitment | Ministry of AYUSH Job

Coronavirus – UK launches clinical trial of BCG vaccine
  • BiotechToday
  • World

Coronavirus – UK launches clinical trial of BCG vaccine

bioxone October 11, 2020October 11, 2020

Saptaparna Pal, Amity University Kolkata

The UK doctors have launched a clinical trial to know whether the cheap and commonly available Bacillus Calmette Guerin BCG vaccine can boost the immune system to prevent healthcare worker from getting affected by a coronavirus.

The primary goal of the vaccine is to stimulate the adaptive immune system. This being the body’s highly targeted second line of defence unleashes antibodies and T-cells to wipe out invading pathogens. In case the trial proves that BCG works against coronavirus, Campbell said it can buy the world crucial time to develop the more effective and targeted vaccine which is needed to bring the pandemic under control.

Since the pandemic has started, scientists have found evidence that BCG vaccination might help to reduce Covid19 deaths, but the results are mixed and contested. 

Mihia Netea, a researcher at Radbourd University in the Netherlands, said BCG appears to train the body’s first line of defence and makes it more active against future infections. It is predicted that BCG can strengthen the initial response, to make the immune system fight back and early, so that the virus doesn’t get any chance to multiply. 

The BCG trial could release preliminary results in 6-9 months. While BCG raises a specific immune response against tuberculosis TB, studies had found that the vaccine also prevents and protects against viral infections. The BCG vaccine lasts for a minimum of 15yrs and maximum 40yrs. Lastly, the BCG vaccine almost stimulates a broader immune response that helps the body keep other infections away too.

Also read: CRISPR unlocks its potential to diagnose Covid-19 within 5 minutes

Source: https://www.msn.com/en-gb/news/world/coronavirus-uk-launches-clinical-trial-of-bcg-vaccine/ar-BB19SSGw

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged BCG COVID BCG vaccine BCG vaccine COVID corona vaccine last coronavirus vaccine news the UK coronavirus vaccine progress how long does BCG vaccine last latest coronavirus vaccine news Nancy Pelosi tuberculosis vaccine vaccine coronavirus

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

CCRAS-NARIP Govt Research Recruitment | Ministry of AYUSH Job

bioxone October 11, 2020

-Shristi Sharma, Team bioXone CCRAS-NARIP Govt Research Recruitment – Ministry of AYUSH Job. MSc Biochemistry SRF Post. Govt Senior Research Fellow Jobs for Biochemistry applicants. Interested and eligible applicants can check out all of the details on the same below: Walk-in-interview for the following post under IMR project of CCRAS, New Delhi will certainly be […]

Related Post

  • BiotechToday
  • World

Antimicrobial surfaces to reduce bacterial build-up on medical instruments

bioxone May 22, 2021May 22, 2021

Aakancha Shaw, St. Xavier’s College, Kolkata The researchers of Monash University have developed new antimicrobial surfaces that can efficiently reduce the formation of bacteria on medical instruments, including urinary catheters, and hence can reduce the risk of patient infection while in hospital. This world-class study proves the ability of these 3D-engineered surfaces in preventing the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Soil Microbes Consume Atmospheric Hydrogen

bioxone October 9, 2020October 8, 2020

SHRESTHA DUTTA, AMITY UNIVERSITY KOLKATA Soil microbes use up atomic hydrogen (H2) from the Earth’s atmosphere and serve as the primary sink in the global biogeochemical H2 cycle as indicated in the field and lab-based examinations. Hydrogen oxidation in soil follows biphasic kinetics with both high-affinity (Km < 100 nM) and low-affinity (Km > 1000 nM) enzyme action. It is to […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Greed for fatty acids become lethal for cancer

BioTech Today June 19, 2021June 19, 2021

Ananya Dutta, Bose Institute The contribution of several nutrients to cancer cells’ biosynthetic, bioenergetic, and antioxidant requirements has been intensively researched over the last decade. The connection between cancer genetics and metabolic rewiring, in particular, has resulted in significant findings, opening up new treatment avenues for certain cancer types. Clinicians are interested in how food […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy